Shilpa Medicare to acquire FTF Pharma for Rs 75 crore, pick up 40pc stake in Auxilla Pharma for Rs 60 crore
Advertisement
New Delhi: Shilpa Medicare Ltd, recently said that it is all set to acquire FTF Pharma Private Limited while it will also pick up a 40% stake in Auxilla Pharmaceuticals And Research LLP.
Shilpa Medicare will fully acquire FTF Pharma for an enterprise value of Rs 75 crore ($9.8 million at current exchange rate). This acquisition, subject to any requisite approvals, will help Shilpa Medicare enhance its research and development facilities, as well as increase its product portfolio, the firm said in the filing.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.